CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-29 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 58,333 | ||
| 2022-08-16 | Smith Brendan Chief Financial Officer | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2022-08-16 | Kulkarni Samarth Chief Executive Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2022-08-16 | Kulkarni Samarth Chief Executive Officer | Grant or award · Performance-based Restricted Stock Units | +150,000 | 150,000 | ||
| 2022-08-16 | Klein Lawrence Otto CBO & COO | Grant or award · Restricted Stock Units | +12,500 | 12,500 | ||
| 2022-08-16 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Option exercise | +8,333 | $12.57 | $105K | 298,612 |
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Option exercise | +16,667 | $16.21 | $270K | 315,279 |
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Sale | −6,933 | $75.64 | $524K | 308,346 |
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Sale | −700 | $76.37 | $53K | 307,646 |
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Sale | −700 | $77.79 | $54K | 306,946 |
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Sale | −12,759 | $75.73 | $966K | 294,187 |
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Sale | −3,308 | $76.29 | $252K | 290,879 |
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Sale | −600 | $77.97 | $47K | 290,279 |
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −8,333 | 0 | ||
| 2022-07-27 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −16,667 | 83,333 | ||
| 2022-06-29 | Kulkarni Samarth Chief Executive Officer | Option exercise | +25,000 | $12.57 | $314K | 315,279 |
| 2022-06-29 | Kulkarni Samarth Chief Executive Officer | Sale | −20,260 | $61.42 | $1.2M | 295,019 |
| 2022-06-29 | Kulkarni Samarth Chief Executive Officer | Sale | −4,740 | $62.32 | $295K | 290,279 |
| 2022-06-29 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 8,333 |
Page 21 of 46 · 910 trades